PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $887,671 | -7.5% | 22,153 | -5.7% | 0.37% | -10.2% |
| Q1 2023 | $959,157 | +2.3% | 23,503 | -3.2% | 0.41% | -1.4% |
| Q4 2022 | $937,296 | -30.8% | 24,276 | -4.6% | 0.42% | -29.7% |
| Q3 2022 | $1,354,000 | -5.4% | 25,450 | +3.7% | 0.59% | +6.8% |
| Q2 2022 | $1,431,000 | -24.7% | 24,539 | -1.5% | 0.56% | -6.1% |
| Q1 2022 | $1,901,000 | +25.1% | 24,906 | -1.3% | 0.59% | +35.6% |
| Q4 2021 | $1,519,000 | +11.5% | 25,241 | +3.8% | 0.44% | +0.5% |
| Q3 2021 | $1,362,000 | -3.9% | 24,324 | +4.2% | 0.43% | -0.9% |
| Q2 2021 | $1,417,000 | -10.2% | 23,345 | +3.7% | 0.44% | -18.0% |
| Q1 2021 | $1,578,000 | +19.1% | 22,511 | +1.6% | 0.53% | +12.7% |
| Q4 2020 | $1,325,000 | +1.8% | 22,149 | +2.3% | 0.47% | -9.5% |
| Q3 2020 | $1,302,000 | +19.6% | 21,649 | +4.3% | 0.52% | +8.5% |
| Q2 2020 | $1,089,000 | +64.3% | 20,748 | +30.6% | 0.48% | +40.0% |
| Q1 2020 | $663,000 | -28.8% | 15,886 | -19.3% | 0.34% | -17.1% |
| Q4 2019 | $931,000 | +17.0% | 19,680 | -5.8% | 0.42% | +7.5% |
| Q3 2019 | $796,000 | -12.5% | 20,899 | -0.1% | 0.39% | -12.8% |
| Q2 2019 | $910,000 | +20.5% | 20,928 | +5.5% | 0.44% | +16.5% |
| Q1 2019 | $755,000 | -17.9% | 19,829 | -7.2% | 0.38% | -29.1% |
| Q4 2018 | $920,000 | -32.6% | 21,378 | -23.0% | 0.54% | -5.1% |
| Q3 2018 | $1,365,000 | +50.3% | 27,768 | -2.0% | 0.57% | +43.3% |
| Q2 2018 | $908,000 | +2.1% | 28,339 | -0.7% | 0.40% | 0.0% |
| Q1 2018 | $889,000 | -33.0% | 28,549 | -1.7% | 0.40% | -33.4% |
| Q4 2017 | $1,326,000 | – | 29,038 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |